It is the operating environment around it: the data foundation, the governance, and the way sponsors and CDMOs coordinate. BAMI is a framework for diagnosing that environment.
Introduced by Axio BioPharma in its 2026 report AI in Biomanufacturing, BAMI outlines a structured approach for evaluating whether AI systems can realistically move beyond isolated pilots into governed, repeatable, and scalable operational deployment.
The ability to integrate and contextualize data across manufacturing and enterprise systems.
Ownership, monitoring, validation, change control, and inspection readiness for AI-enabled systems.
The ability to transfer models, process knowledge, and operational intelligence across sites and partners.
Alignment across MES, LIMS, historians, analytics layers, and decision workflows.
Preparedness for evolving expectations around AI-enabled systems in GxP environments.
BAMI reflects the operational realities of modern biomanufacturing, where execution increasingly spans sponsors, CDMOs, digital systems, and external partners.
Rather than positioning AI as a standalone capability, the framework considers whether the surrounding operating environment can support scalable and governed AI deployment across sites, organizations, and regulated workflows.
It also aligns conceptually with broader industry maturity initiatives such as DPMM and DISCO, helping organizations connect digital maturity with practical AI capability and deployment readiness.
BAMI — the Biomanufacturing AI Maturity Index — is a framework introduced by Axio BioPharma in its 2026 report AI in Biomanufacturing. It diagnoses whether the operating environment around AI — the data foundation, the governance, and the way sponsors and CDMOs coordinate — can support moving AI beyond isolated pilots into governed, repeatable, and scalable operational deployment.
BAMI evaluates readiness across five critical dimensions: (1) data foundation & cross-system interoperability, (2) model lifecycle governance & validation, (3) process portability & model-driven tech transfer, (4) operational integration, and (5) regulatory alignment & inspection readiness.
The blocker is rarely the model. It is the operating environment around it — the data foundation, the governance, and the way sponsors and CDMOs coordinate. BAMI is a framework for diagnosing that environment so AI can move past isolated pilots.
Take the BAMI assessment to evaluate your AI readiness across the five dimensions and pinpoint operational and governance gaps — or read the full framework in the 2026 report AI in Biomanufacturing.
BAMI aligns conceptually with broader industry maturity initiatives such as DPMM and DISCO, helping organizations connect digital maturity with practical AI capability and deployment readiness.
Evaluate your AI readiness across the five BAMI dimensions, pinpoint operational and governance gaps, and see what it takes to support scalable, governed AI in manufacturing. Or read the full framework in the 2026 report.
